EPISAS | Linksium
Back to portfolio

EPISAS

Commercialization

Sleep Apnea predicted by AI

profilePhoto   Christine Melay
Linksium Contact Christine Melay +33 (0)6 21 77 19 90 christine.melay@linksium.fr
Rm373batch5 18

Benefits

  • Sleep apnea prediction
  • Speed
  • Accuracy

Key words

  • Sleep apnea-hypopnea syndrome
  • Geometric morphometry
  • Artificial intelligence
  • Medical device

Intellectual Property

  • 1 patent

Laboratory

  • HP2

Institutions

  • INSERM
  • UGA

Linksium Continuum

  • Maturation
  • Commercialization

Results

  • Available licenses

Context

With 4% of the world's population affected, according to the WHO, obstructive sleep apnea-hypopnea syndrome (OSAHS) is a major health and economic issue.

Today, nearly 80% of the affected population remains undiagnosed diagnosed in the world.

Technology

The EPISAS project consists in developing an innovative medical device based on geometric morphometry and artificial intelligence, for the screening of OSA.

Advantages

Episas is a solution for screening for OSA using a simple, quick-to-use, non-irradiating and non-invasive device.

State of progress

The Episas solution is now at the proof-of-concept stage. An initial study on nearly 300 patients has led to the development of a solution that achieving an accuracy of nearly 70%.

Applications

The EPISAS solution will provide practitioners with a simple and rapid system that facilitates the choice of different orientations for patients in their care pathway.

Close projects index

U

X